ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.039 AUD -4.88% Market Closed
Market Cap: 79.2m AUD

Intrinsic Value

The intrinsic value of one IPD stock under the Base Case scenario is 0.034 AUD. Compared to the current market price of 0.039 AUD, ImpediMed Ltd is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IPD Intrinsic Value
0.034 AUD
Overvaluation 12%
Intrinsic Value
Price
Base Case Scenario

Valuation History
ImpediMed Ltd

What is Valuation History?
Compare IPD to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IPD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ImpediMed Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
ImpediMed Ltd

Current Assets 27.5m
Cash & Short-Term Investments 22.2m
Receivables 3.7m
Other Current Assets 1.7m
Non-Current Assets 14.2m
Long-Term Investments 73k
PP&E 883k
Intangibles 13m
Other Non-Current Assets 227k
Efficiency

Free Cash Flow Analysis
ImpediMed Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ImpediMed Ltd

Revenue
12.7m AUD
Cost of Revenue
-1.7m AUD
Gross Profit
11m AUD
Operating Expenses
-34m AUD
Operating Income
-23m AUD
Other Expenses
-230k AUD
Net Income
-23.2m AUD
Fundamental Scores

IPD Profitability Score
Profitability Due Diligence

ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
24/100
Profitability
Score

ImpediMed Ltd's profitability score is 24/100. The higher the profitability score, the more profitable the company is.

IPD Solvency Score
Solvency Due Diligence

ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Negative Net Debt
53/100
Solvency
Score

ImpediMed Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.107 AUD with a low forecast of 0.071 AUD and a high forecast of 0.147 AUD.

Lowest
Price Target
0.071 AUD
81% Upside
Average
Price Target
0.107 AUD
175% Upside
Highest
Price Target
0.147 AUD
277% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

ImpediMed Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for IPD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IPD stock?

The intrinsic value of one IPD stock under the Base Case scenario is 0.034 AUD.

Is IPD stock undervalued or overvalued?

Compared to the current market price of 0.039 AUD, ImpediMed Ltd is Overvalued by 12%.

Back to Top